#United States #Anaheim #ADLM #Laboratory Medicine #Corporate Supporter

ADLM Celebrates Its 2026 Top Corporate Supporters

In a significant event held on July 28, 2026, the Association for Diagnostics & Laboratory Medicine (ADLM) recognized the recipients of its esteemed 2026 Top Corporate Supporter Award. This accolade highlights the integral roles played by various organizations that consistently support the association through various channels, including advertising, sponsorships, and exhibits. With these vital contributions, ADLM can advance its mission: ensuring better health for everyone by emphasizing the importance of laboratory medicine.

The award ceremony took place during the ADLM 2026 conference in Anaheim, California, an event noted for its extensive range of topics covering the latest advancements in clinical laboratory medicine. This year, a total of 42 organizations were celebrated for their commitment and support to ADLM. As these companies received their accolades, representatives from the ADLM Board of Directors underscored the significance of partnerships in pushing the frontiers of laboratory medicine forward.

Among the distinguished awardees were notable names such as Abbott, Siemens Healthineers, and Roche Diagnostics Corporation, as well as many others, including BD Integrated Diagnostic Solutions, Thermo Fisher Scientific, and Bio-Rad Laboratories. Each of these contributors plays a crucial role in the diagnostic landscape by providing essential technologies and services that enhance patient care.

ADLM’s CEO, Melanie J. Wells, expressed profound gratitude towards the award recipients, stating, "Congratulations to this year's Top Corporate Supporter Award recipients, and thank you for your steadfast partnership. Your commitment to ADLM has been instrumental in driving our work forward and strengthening the laboratory medicine profession. Thanks to your generous engagement, we are able to provide laboratory medicine professionals with the resources they need to succeed in their careers and to ensure that patients get accurate diagnoses and effective care."

The ADLM 2026 event offers attendees five days filled with groundbreaking discussions and learning opportunities from July 26 to 30. Plenary sessions feature advances in various medical fields, including landmark studies on diabetes, the health challenges faced by astronauts, and the relationship between diseases like Alzheimer's and Down syndrome. Furthermore, new insights into cervical cancer screening and innovative cancer biomarker technologies are also on the agenda.

Participants in the ADLM 2026 Clinical Lab Expo will witness the latest in diagnostic technology, with over 700 exhibitors representing the forefront of innovation in the field. Topics such as artificial intelligence in diagnostics, point-of-care solutions, and automation technologies are presented to enhance the efficiency and effectiveness of laboratory diagnoses.

The Association for Diagnostics & Laboratory Medicine unites over 70,000 professionals from various backgrounds, including clinical laboratory personnel, physicians, researchers, and business leaders from over 110 countries. The ADLM is dedicated to promoting advancements in laboratory medicine, fostering scientific collaboration, and enhancing knowledge sharing to achieve better health outcomes for all. Founded in 1948, the organization continually endeavors to nurture the growth of laboratory medicine with innovative solutions.

For more information about ADLM and its initiatives, visit www.myadlm.org.